These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 19486012)

  • 1. Gene expression profiling of advanced-stage serous ovarian cancers distinguishes novel subclasses and implicates ZEB2 in tumor progression and prognosis.
    Yoshihara K; Tajima A; Komata D; Yamamoto T; Kodama S; Fujiwara H; Suzuki M; Onishi Y; Hatae M; Sueyoshi K; Fujiwara H; Kudo Y; Inoue I; Tanaka K
    Cancer Sci; 2009 Aug; 100(8):1421-8. PubMed ID: 19486012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-200c modulates ovarian cancer cell metastasis potential by targeting zinc finger E-box-binding homeobox 2 (ZEB2) expression.
    Lu YM; Shang C; Ou YL; Yin D; Li YN; Li X; Wang N; Zhang SL
    Med Oncol; 2014 Aug; 31(8):134. PubMed ID: 25052237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZEB2 facilitates peritoneal metastasis by regulating the invasiveness and tumorigenesis of cancer stem-like cells in high-grade serous ovarian cancers.
    Li Y; Fei H; Lin Q; Liang F; You Y; Li M; Wu M; Qu Y; Li P; Yuan Y; Chen T; Jiang H
    Oncogene; 2021 Aug; 40(32):5131-5141. PubMed ID: 34211089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZEB2 promotes the metastasis of gastric cancer and modulates epithelial mesenchymal transition of gastric cancer cells.
    Dai YH; Tang YP; Zhu HY; Lv L; Chu Y; Zhou YQ; Huo JR
    Dig Dis Sci; 2012 May; 57(5):1253-60. PubMed ID: 22350782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expressions of ZEB2 and C-myc in epithelial ovarian cancer and their clinical significance].
    Wang Q; Jiang H; Deng X; Fang W; Guo S
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Dec; 35(12):1765-9. PubMed ID: 26714913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro.
    Kahlert C; Lahes S; Radhakrishnan P; Dutta S; Mogler C; Herpel E; Brand K; Steinert G; Schneider M; Mollenhauer M; Reissfelder C; Klupp F; Fritzmann J; Wunder C; Benner A; Kloor M; Huth C; Contin P; Ulrich A; Koch M; Weitz J
    Clin Cancer Res; 2011 Dec; 17(24):7654-63. PubMed ID: 22042972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cdc42/Rac1 regulator CdGAP is a novel E-cadherin transcriptional co-repressor with Zeb2 in breast cancer.
    He Y; Northey JJ; Pelletier A; Kos Z; Meunier L; Haibe-Kains B; Mes-Masson AM; Côté JF; Siegel PM; Lamarche-Vane N
    Oncogene; 2017 Jun; 36(24):3490-3503. PubMed ID: 28135249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role and prognostic significance of the epithelial-mesenchymal transition factor ZEB2 in ovarian cancer.
    Prislei S; Martinelli E; Zannoni GF; Petrillo M; Filippetti F; Mariani M; Mozzetti S; Raspaglio G; Scambia G; Ferlini C
    Oncotarget; 2015 Aug; 6(22):18966-79. PubMed ID: 26136338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein expression of ZEB2 in renal cell carcinoma and its prognostic significance in patient survival.
    Fang Y; Wei J; Cao J; Zhao H; Liao B; Qiu S; Wang D; Luo J; Chen W
    PLoS One; 2013; 8(5):e62558. PubMed ID: 23658743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2.
    Park SM; Gaur AB; Lengyel E; Peter ME
    Genes Dev; 2008 Apr; 22(7):894-907. PubMed ID: 18381893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma.
    Guo F; Cogdell D; Hu L; Yang D; Sood AK; Xue F; Zhang W
    Oncol Rep; 2014 May; 31(5):2021-8. PubMed ID: 24677166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma.
    Elloul S; Elstrand MB; Nesland JM; Tropé CG; Kvalheim G; Goldberg I; Reich R; Davidson B
    Cancer; 2005 Apr; 103(8):1631-43. PubMed ID: 15742334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotinamide N-methyltransferase overexpression may be associated with poor prognosis in ovarian cancer.
    Harmankaya İ; Akar S; Uğraş S; Güler AH; Ezveci H; Aydoğdu M; Çelik Ç
    J Obstet Gynaecol; 2021 Feb; 41(2):248-253. PubMed ID: 32285726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Title Prognosis Significance of ZEB2 and TGF-β1 as well as Other Clinical Characteristics in Epithelial Ovarian Cancer.
    Yan Z; Tian X; Wang R; Cheng X; Mi J; Xiong L; Wang Y; Deng J; Jia M
    Int J Gynecol Cancer; 2017 Sep; 27(7):1343-1349. PubMed ID: 30814239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZEB2 mediates multiple pathways regulating cell proliferation, migration, invasion, and apoptosis in glioma.
    Qi S; Song Y; Peng Y; Wang H; Long H; Yu X; Li Z; Fang L; Wu A; Luo W; Zhen Y; Zhou Y; Chen Y; Mai C; Liu Z; Fang W
    PLoS One; 2012; 7(6):e38842. PubMed ID: 22761708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition.
    Bendoraite A; Knouf EC; Garg KS; Parkin RK; Kroh EM; O'Briant KC; Ventura AP; Godwin AK; Karlan BY; Drescher CW; Urban N; Knudsen BS; Tewari M
    Gynecol Oncol; 2010 Jan; 116(1):117-25. PubMed ID: 19854497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-150 predicts a favorable prognosis in patients with epithelial ovarian cancer, and inhibits cell invasion and metastasis by suppressing transcriptional repressor ZEB1.
    Jin M; Yang Z; Ye W; Xu H; Hua X
    PLoS One; 2014; 9(8):e103965. PubMed ID: 25090005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validating the impact of a molecular subtype in ovarian cancer on outcomes: a study of the OVCAD Consortium.
    Pils D; Hager G; Tong D; Aust S; Heinze G; Kohl M; Schuster E; Wolf A; Sehouli J; Braicu I; Vergote I; Cadron I; Mahner S; Hofstetter G; Speiser P; Zeillinger R
    Cancer Sci; 2012 Jul; 103(7):1334-41. PubMed ID: 22497737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of differentially expressed genes using an annealing control primer system in stage III serous ovarian carcinoma.
    Kim YS; Hwan JD; Bae S; Bae DH; Shick WA
    BMC Cancer; 2010 Oct; 10():576. PubMed ID: 20969748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2.
    Wu Q; Guo R; Lin M; Zhou B; Wang Y
    Gynecol Oncol; 2011 Jul; 122(1):149-54. PubMed ID: 21529905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.